Study S003282

An Open-label, Fixed-sequence, Two-part Study to Assess the Effect of AZD5004 on the Pharmacokinetics of Mitiglinide and Pioglitazone in Healthy Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07444424
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 32
Start: 2026-03-13
Primary completion: 2026-07-02
Lead sponsor: AstraZeneca
Conditions: Healthy Participants
Interventions: DRUG:AZD5004; DRUG:Mitiglinide; DRUG:Pioglitazone
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Area under concentration-time curve from time 0 to infinity (AUCinf) [Part A: From Day 1 to Day 50; Part B: From Day 1 to Day 70]
Area under concentration-curve from time 0 to the last quantifiable concentration (AUClast) [Part A: From Day 1 to Day 50; Part B: From Day 1 to Day 70]
Maximum observed drug concentration (Cmax) [Part A: From Day 1 to Day 50; Part B: From Day 1 to Day 70]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.